|
|
  
The National Methamphetamine
Drug Conference
The conference workgroups opened with briefings from experts and practitioners followed by open discussion of the group theme. The purpose of the briefings was to stimulate thought, discussion, and recommendations on the broader themes of: prevention, education, treatment, clandestine labs, drug courts, and precursor chemical control. What follows is a brief digest of this workgroup activity. The briefings are given in order of presentation.
Prevention
- Gabriel Georges Nahas, M.D., Ph.D., New York University Medical Center
- Eve Bachrach, J.D., Nonprescription Drug Manufacturers Association
- Jim Kielley, Warner-Lambert
- Leslie Bloom, Partnership for a Drug-Free America
- David Hatcher, Hatcher and Associates
- Discussion
Education
- David Walker, North Carolina Partnership for Children
- William Alden, D.A.R.E. America
- Dick Palmquist and Karen Walklin, Nebraska Broadcasters Association
- Cathy Siders, Ph.D., Psychologist
- Discussion
Treatment
- Michael Sise, M.D., Mercy Hospital
- Richard Rawson, Ph.D., The Matrix Institute
- Rebecca Games, Games and Associates
- Discussion
Clandestine Labs
- George J. Doane, California Bureau of Narcotic Enforcement
- Scott Lukas, Ph.D., Harvard Medical School
- Karl Palmer, California Department of Toxic Substance Control
- Terry Brubaker, U.S. Environmental Protection Agency, Region 9
- Discussion
Drug Courts
- Judge Richard Shull, Municipal Court, Wichita, Kansas
- Tom Leland, M.D., Community Care Services
- Alice Huber, Ph.D., the Matrix Institute
- Judge James Livingston, District Judge, Grand Island, Nebraska
- Larry Ferrell, J.D., Assistant U.S. Attorney, Missouri
- Discussion
Precursor Chemical Control
- Walter Ling, M.D., The Matrix Institute
- Harry Matz, J.D., U.S. Department of Justice
- Edward Machado, California Bureau of Narcotic Enforcement
- William Wolf, U.S. Drug Enforcement Administration
- Discussion
|
